Sangamo Therapeutics News

Sangamo Therapeutics | DEF 14A: Definitive information statements

Apr 19 16:06 ET

Sangamo Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 3 17:21 ET

Sangamo Therapeutics | 8-K: Current report

Mar 25 17:09 ET

Sangamo Therapeutics | 8-K: SANGAMO THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS

Mar 13 07:58 ET

Sangamo Therapeutics | 8-K: Current report

Feb 6 16:39 ET

Sangamo Therapeutics | 8-K: Current report

Jan 19 00:00 ET

Sangamo Therapeutics | 8-K: Current report

Dec 13, 2023 07:55 ET

Sangamo Therapeutics | 8-K: Current report

Nov 3, 2023 16:02 ET

Sangamo Therapeutics | 8-K: SANGAMO THERAPEUTICS ANNOUNCES STRATEGIC UPDATE AND REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS

Nov 1, 2023 16:02 ET

Sangamo Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 8, 2023 16:47 ET

Sangamo Therapeutics | 8-K: SANGAMO THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND SECOND QUARTER 2023 FINANCIAL RESULTS

Aug 8, 2023 16:08 ET

Sangamo Therapeutics | 8-K: Current report

Jun 2, 2023 16:58 ET

Sangamo Therapeutics | 8-K: SANGAMO THERAPEUTICS ANNOUNCES STRATEGIC UPDATE AND REPORTS PRELIMINARY FIRST QUARTER 2023 FINANCIAL RESULTS

Apr 26, 2023 17:22 ET

Sangamo Therapeutics | DEF 14A: Definitive proxy statements

Apr 17, 2023 06:03 ET

Sangamo Therapeutics | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition

Apr 5, 2023 16:01 ET

Sangamo Therapeutics | 8-K: Current report

Mar 17, 2023 17:14 ET

Sangamo Therapeutics | 8-K: Current report

Mar 14, 2023 09:43 ET

Sangamo Therapeutics | 8-K: Current report

Mar 10, 2023 17:17 ET

Sangamo Therapeutics | 8-K: Current report

Mar 7, 2023 06:49 ET

Sangamo Therapeutics | 8-K: Current report

Mar 2, 2023 17:05 ET